Neutralizing antibody formation is rare following repeated injections of a low-protein formulation of botulinum toxin type A (BTX-A) in patients with post-stroke spasticity - Turkel,C.; Dru,R.; Daggett,S.; Brin,M. (Neurology, 2002)